Uni-Bio Science Group Announces 2025 Interim Results
Source: Media Outreach EPS Surged to 1.27 HK Cents with a Three-year CAGR of 43.1%, Robust Revenue Growth Driven by Strong Demand for Bogutai® and Omnichannel Strategy HONG KONG SAR – EQS Newswire – 28 August 2025 – A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (“Uni-Bio Science”, together with its subsidiaries referred … Read more